Brooklyn Immunotherapeutics Inc (BTX) stock is down -94.90% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BTX stock a score of 25 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 3. BTX's rank also includes a long-term technical score of 6. BTX has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on BTX!